Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptorβ in primary invasive breast carcinomas

Breast Cancer Research and Treatment

Volumn 111, Issue 3, 2008, Pages 453-459

  Bates, Gaynor J ^a   Fox, Stephen B ^b   Han, Cheng ^c   Launchbury, Rosalind ^a   Leek, Russell D ^a   Harris, Adrian L ^c   Banham, Alison H ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Breast cancer; Estrogen receptor ; Forkhead; FOXP1

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FORKHEAD TRANSCRIPTION FACTOR; SMALL INTERFERING RNA; TAMOXIFEN; TRANSCRIPTION FACTOR FOXP1; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER EPIDEMIOLOGY; CANCER GRADING; CELL NUCLEUS; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN TISSUE; INVASIVE CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; REPRESSOR PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 51649090690     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9812-4     Document Type: Article

References (25)

1. B Wang J Weidenfeld MM Lu 2004 Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation Development 131 18 4477 4487
2. AH Banham N Beasley E Campo 2001 The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p Cancer Res 61 24 8820 8829
3. SB Fox P Brown C Han 2004 Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor alpha and improved survival in primary human breast carcinomas Clin Cancer Res 10 10 3521 3527
4. I Bieche R Lidereau 1995 Genetic alterations in breast cancer Genes Chromosomes Cancer 14 4 227 251
5. A Martinez RA Walker JA Shaw 2001 Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features Mol Pathol 54 5 300 306
6. A Giatromanolaki MI Koukourakis E Sivridis 2006 Loss of expression and nuclear/cytoplasmic localization of the FOXP1 forkhead transcription factor are common events in early endometrial cancer: relationship with estrogen receptors and HIF-1alpha expression Mod Pathol 19 1 9 16
7. AH Banham J Boddy R Launchbury 2007 Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the Androgen receptor in prostate cancer but is not directly regulated by Androgens or hypoxia Prostate 67 10 1091 1098
8. S Ali RC Coombes 2002 Endocrine-responsive breast cancer and strategies for combating resistance Nat Rev Cancer 2 2 101 112
9. LC Murphy PH Watson 2006 Is oestrogen receptor-beta a predictor of endocrine therapy responsiveness in human breast cancer? Endocr Relat Cancer 13 2 327 334
10. V Speirs RA Walker 2007 New perspectives into the biological and clinical relevance of oestrogen receptors in the human breast J Pathol 211 5 499 506
11. SK Gruvberger-Saal PO Bendahl LH Saal 2007 Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma Clin Cancer Res 13 7 1987 1994
12. WL McGuire 1975 Current status of estrogen receptors in human breast cancer Cancer 36 2 638 644
13. (1998) Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 351(9114):1451-1467
14. V Speirs GP Skliris SE Burdall 2002 Distinct expression patterns of ER alpha and ER beta in normal human mammary gland J Clin Pathol 55 5 371 374
15. Elston C (1987) Grading of invasive carcinoma of the breast. In: Page D, Anderson T (eds) Diagnostic histopathology of the breast. Churchill Livingstone, Edinburgh, pp 300-311
16. JF Couse KS Korach 1999 Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20 3 358 417
17. MM Liu C Albanese CM Anderson 2002 Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression J Biol Chem 277 27 24353 24360
18. P Pajer V Pecenka J Kralova 2006 Identification of potential human oncogenes by mapping the common viral integration sites in avian nephroblastoma Cancer Res 66 1 78 86
19. V Speirs PJ Carder S Lane 2004 Oestrogen receptor beta: what it means for patients with breast cancer Lancet Oncol 5 3 174 181
20. V Speirs M Parker A Green 2006 Progress towards unlocking the secrets of oestrogen receptor beta in breast cancer Breast Cancer Res 8 Suppl 2 P24
21. N Heldring A Pike S Andersson 2007 Estrogen receptors: how do they signal and what are their targets Physiol Rev 87 3 905 931
22. GP Skliris K Munot SM Bell 2003 Reduced expression of oestrogen receptor beta in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line model J Pathol 201 2 213 220
23. C Zhao EW Lam A Sunters 2003 Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation Oncogene 22 48 7600 7606
24. SJ Kim TW Kim SY Lee 2004 CpG methylation of the ERalpha and ERbeta genes in breast cancer Int J Mol Med 14 2 289 293
25. A Rody U Holtrich C Solbach 2005 Methylation of estrogen receptor beta promoter correlates with loss of ER-beta expression in mammary carcinoma and is an early indication marker in premalignant lesions Endocr Relat Cancer 12 4 903 916